<DOC>
	<DOCNO>NCT00594945</DOCNO>
	<brief_summary>Evaluate safety efficacy intranasal Clonazepam subject epilepsy .</brief_summary>
	<brief_title>Study Intranasal Clonazepam Adult Subjects With Epileptic Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>Diagnosis refractory epilepsy No Nasal condition would preclude use intranasal product Subject clinical significant unstable medical abnormality Subject currently regularly take Clonazepam</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>